GHOSH ANIRVAN (Chief Executive Officer) sold 1.6% of their position (1.21K shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $1.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2024ACC: 0000950170-24-077849
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-1.21K
Net shares
Net seller
$1.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.21K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−1.21K
Price / share
$1.40
Trade value
$1.70K
% of position
1.6%
6/25/2024
78.14K→76.93K
Total
Net shares
−1.21K
Net value
-$1.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 6/25/2024 | S · Sale | −1.21K | $1.40 | $1.70K | 1.6% | 78.14K | 76.93K |
| Total | −1.21K | -$1.70K | ||||||
Derivative Transactions0
No derivative transactions reported